Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral… Read more
Market Cap & Net Worth: Globus Medical (GMED)
Globus Medical (NYSE:GMED) has a market capitalization of $9.82 Billion ($9.82 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1718 globally and #1266 in its home market, demonstrating a 0.40% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Globus Medical's stock price $88.16 by its total outstanding shares 111409069 (111.41 Million).
Globus Medical Market Cap History: 2015 to 2026
Globus Medical's market capitalization history from 2015 to 2026. Data shows growth from $3.10 Billion to $9.82 Billion (13.65% CAGR).
Index Memberships
Globus Medical is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.04 Trillion | 0.32% | #100 of 401 |
Weight: Globus Medical's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Globus Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Globus Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.66x
Globus Medical's market cap is 3.66 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
89.48x
Globus Medical's market cap is 89.48 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.10 Billion | $544.75 Million | $112.78 Million | 5.69x | 27.48x |
| 2016 | $2.76 Billion | $563.99 Million | $104.34 Million | 4.90x | 26.49x |
| 2017 | $4.58 Billion | $635.98 Million | $107.35 Million | 7.20x | 42.65x |
| 2018 | $4.82 Billion | $712.97 Million | $156.47 Million | 6.76x | 30.82x |
| 2019 | $6.56 Billion | $785.37 Million | $155.21 Million | 8.35x | 42.26x |
| 2020 | $7.27 Billion | $789.04 Million | $102.28 Million | 9.21x | 71.04x |
| 2021 | $8.04 Billion | $958.10 Million | $149.19 Million | 8.40x | 53.92x |
| 2022 | $8.27 Billion | $1.02 Billion | $190.17 Million | 8.09x | 43.51x |
| 2023 | $5.94 Billion | $1.57 Billion | $122.87 Million | 3.79x | 48.32x |
| 2024 | $9.21 Billion | $2.52 Billion | $102.98 Million | 3.66x | 89.48x |
Competitor Companies of GMED by Market Capitalization
Companies near Globus Medical in the global market cap rankings as of March 18, 2026.
Key companies related to Globus Medical by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Globus Medical Historical Marketcap From 2015 to 2026
Between 2015 and today, Globus Medical's market cap moved from $3.10 Billion to $ 9.82 Billion, with a yearly change of 13.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $9.82 Billion | +0.97% |
| 2025 | $9.73 Billion | +5.56% |
| 2024 | $9.21 Billion | +55.21% |
| 2023 | $5.94 Billion | -28.25% |
| 2022 | $8.27 Billion | +2.87% |
| 2021 | $8.04 Billion | +10.70% |
| 2020 | $7.27 Billion | +10.77% |
| 2019 | $6.56 Billion | +36.04% |
| 2018 | $4.82 Billion | +5.30% |
| 2017 | $4.58 Billion | +65.66% |
| 2016 | $2.76 Billion | -10.82% |
| 2015 | $3.10 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Globus Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.82 Billion USD |
| MoneyControl | $9.82 Billion USD |
| MarketWatch | $9.82 Billion USD |
| marketcap.company | $9.82 Billion USD |
| Reuters | $9.82 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.